133 related articles for article (PubMed ID: 4190097)
1. [Hemotherapy with an antithrombin-antiplasmin concentrate of human plasma (alpha2-macroglobulin concentrate)].
Marx R; Matis P
Med Welt; 1969 Dec; 50():2718-22. PubMed ID: 4190097
[No Abstract] [Full Text] [Related]
2. Control of coagulation and fibrinolysis by plasma proteinase inhibitors.
Travis J; Salvesen G
Behring Inst Mitt; 1983 Aug; (73):56-65. PubMed ID: 6206838
[TBL] [Abstract][Full Text] [Related]
3. [Antiplasmin, antitrypsin and antithrombin activity of alpha-2-macroglobulin].
Steinbuch M; Blatrix C; Josso F
Transfusion (Paris); 1967; 10(1):103-20. PubMed ID: 6048644
[No Abstract] [Full Text] [Related]
4. [Increased fibrinolytic activity in thrombocytopenia and its therapeutic modification by PAMBA].
Thiele G
Z Arztl Fortbild (Jena); 1969 Dec; 63(24):1296-8. PubMed ID: 5403440
[No Abstract] [Full Text] [Related]
5. A method for the differential determination of plasma antithrombins.
Musumeci V; Vincenti A; Bizzi B
J Clin Pathol; 1976 Jan; 29(1):63-8. PubMed ID: 55420
[TBL] [Abstract][Full Text] [Related]
6. The measurement of human plasma antiplasmin activity by radial diffusion assay.
Andes WA
Thromb Haemost; 1978 Apr; 39(2):437-49. PubMed ID: 79230
[TBL] [Abstract][Full Text] [Related]
7. Alpha2-antiplasmin and its deficiency: fibrinolysis out of balance.
Carpenter SL; Mathew P
Haemophilia; 2008 Nov; 14(6):1250-4. PubMed ID: 19141165
[TBL] [Abstract][Full Text] [Related]
8. [Effect of antithrombin III on anticoagulating system function in animals intravenously injected with tissue thromboplastin].
Pastorova VE; Kovalev SV
Vopr Med Khim; 1976; 22(2):240-5. PubMed ID: 1025886
[TBL] [Abstract][Full Text] [Related]
9. [Therapy of acquired hemorrhagic diatheses].
Heene D; Schultis K
Med Welt; 1968 Apr; 15():985-7. PubMed ID: 5305016
[No Abstract] [Full Text] [Related]
10. [Surgical hemorrhagic syndrome. Elaboration of a practical procedure of investigation and treatment in the absence of a specialized laboratory].
Otteni JC; Boyer C; Girardel JM; Gauthier-Lafaye JP
Anesth Analg (Paris); 1969; 26(1):89-106. PubMed ID: 5793321
[No Abstract] [Full Text] [Related]
11. Hydroxyethyl starch enhances fibrinolysis in human plasma by diminishing alpha2-antiplasmin-plasmin interactions.
Nielsen VG
Blood Coagul Fibrinolysis; 2007 Oct; 18(7):647-56. PubMed ID: 17890952
[TBL] [Abstract][Full Text] [Related]
12. [Detection of a thrombotic tendency by means of coagulation tests (author's transl)].
von Kaulla E; von Kaulla KN
MMW Munch Med Wochenschr; 1974 Aug; 116(31):1387-96. PubMed ID: 4212608
[No Abstract] [Full Text] [Related]
13. [On the effect of various antifibrinolytic agents on blood coagulation].
Gerl D; Bonow A
Med Klin; 1969 Feb; 64(9):374-8. PubMed ID: 5783025
[No Abstract] [Full Text] [Related]
14. [Congestive Mediterranean splenomegaly and consummation coagulopathy. I. General characteristics of blood coagulation disorders observed in Mediterranean splenomegaly].
Demange J; Berbich A; Hassar ; Maouni ; tTazi-Moha ; Tounsi
Ann Med Interne (Paris); 1969 Dec; 120(12):827-33. PubMed ID: 5377663
[No Abstract] [Full Text] [Related]
15. [Therapy of plasma coagulation defects. II. Acquired coagulation disorders].
Schmutzler R
Dtsch Med Wochenschr; 1966 Feb; 91(7):316-8. PubMed ID: 5295337
[No Abstract] [Full Text] [Related]
16. [Changes of blood coagulation in prostatic surgery, consequences for preventive therapy with antifibrinolytic agents].
Naber K; Bichler KH; Müller KH; Sommerkamp H; Jöhrens H; Porzsolt F
Helv Chir Acta; 1973 Sep; 40(4):519-22. PubMed ID: 4753393
[No Abstract] [Full Text] [Related]
17. [Coagulation disorders in acute gastrointestinal hemorrhage].
Encke A
Fortschr Med; 1974 May; 92(13):542-3. PubMed ID: 4545381
[No Abstract] [Full Text] [Related]
18. [Hyperfibrinolysis].
Marx R; Matis P
Hoppe Seylers Z Physiol Chem; 1968 Jul; 349(7):934-5. PubMed ID: 5303675
[No Abstract] [Full Text] [Related]
19. Overactive fibrinolysis.
Mittal SR
J Indian Med Assoc; 1974 Apr; 62(7):256-9. PubMed ID: 4414962
[No Abstract] [Full Text] [Related]
20. Quantification of the effects of thrombin activatable fibrinolysis inhibitor and alpha2-antiplasmin on fibrinolysis in normal human plasma.
Nielsen VG; Ellis TC
Blood Coagul Fibrinolysis; 2007 Jan; 18(1):29-33. PubMed ID: 17179823
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
